Association between baseline haemoglobin levels and radiographic joint damage progression in patients with rheumatoid arthritis treated with baricitinib or standard of care

Eitemau Tebyg

• A JAK inhibitor for treatment of rheumatoid arthritis: the baricitinib experience
  gan: Taylor, PC, et al.
  Cyhoeddwyd: (2023)
• Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review
  gan: Paul Emery, et al.
  Cyhoeddwyd: (2021-01-01)
• Baricitinib for the treatment of rheumatoid arthritis
  gan: Ivan Urits, et al.
  Cyhoeddwyd: (2020-12-01)
• Baricitinib versus placebo or adalimumab in rheumatoid arthritis
  gan: Taylor, P, et al.
  Cyhoeddwyd: (2017)
• Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors
  gan: Taylor, P, et al.
  Cyhoeddwyd: (2019)